Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-09

Clinical Trial Update: MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is evaluating MRI-guided transurethral urethral ultrasound ablation for low- to intermediate-grade prostate cancer and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | NA | Status: RECRUITING